Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
NCT05809687 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2024-10-24
Summary
Phase 3 study to evaluate the efficacy and safety of DKP21102\_B Added on to DKP21102\_A Compared with DKP21102\_A
Conditions
- Dyslipidemias
Interventions
- DRUG
-
DKP21102_C
Placebo
- DRUG
-
DKP21102_B
Treatment
- DRUG
-
DKP21102_A
Active Control
Sponsors & Collaborators
-
Dongkwang Pharm. Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-01-01
- Primary Completion
- 2026-12-01
- Completion
- 2027-12-01
More Related Trials
-
Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
NCT00688558 ·Status: COMPLETED ·Phase: PHASE2
-
Study of SHR-1209 in the Treatment of Hypercholesterolemia and Hyperlipidemia Ⅲ Stage
NCT04849000 ·Status: COMPLETED ·Phase: PHASE3
-
Dyslipidemia of Obesity Intervention in Teens
NCT02956590 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate MK1903 in Patients With Dyslipidemia (MK1903-004)
NCT00847197 ·Status: COMPLETED ·Phase: PHASE2
-
Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024)
NCT00289900 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of MK0859 on Lipoprotein Metabolism in Patients With Dyslipidemia (0859-026 AM3)
NCT00990808 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of MK0859 in Patients With Primary Hypercholesterolemia or Mixed Hyperlipidemia (MK-0859-011)(COMPLETED)
NCT00565292 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study to Evaluate the Efficacy and Safety of K-877 in Chinese Patients With High TG and Low HDL-C
NCT04998981 ·Status: COMPLETED ·Phase: PHASE3
-
AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
NCT01030328 ·Status: WITHDRAWN ·Phase: PHASE3
-
Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia
NCT00688896 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels
NCT00689442 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of AD-218
NCT05400317 ·Status: RECRUITING ·Phase: PHASE3
-
Study to Assess the Tolerability and Efficacy of Anacetrapib in Patients With Coronary Heart Disease (CHD) or CHD Risk-Equivalent Disease (MK-0859-019)
NCT00685776 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)
NCT01335997 ·Status: TERMINATED ·Phase: PHASE3
-
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
NCT01968967 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Confirmatory Study of K-877 (Pemafibrate) in Patients With Hypercholesterolemia and Statin Intolerance
NCT05923281 ·Status: COMPLETED ·Phase: PHASE3
-
European Trial About Effect of RimoNabant on Abdominal Obese Patients With dysLipidemia
NCT00412698 ·Status: TERMINATED ·Phase: PHASE3
-
Study of Extended Release Niacin/Laropiprant on Lipids (0524A-067)
NCT00479388 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Study of Obicetrapib in Combination With Ezetimibe
NCT04770389 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of JW0108+C2407 in Patients With Dyslipidemia
NCT06955104 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia
NCT01105598 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia
NCT02714569 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia
NCT00487994 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Ezetimibe/Simvastatin 10/20 mg and MK0524A (1-2 g/Day) in Mixed Hyperlipidemia and Two or More Risk Factors
NCT00738985 ·Status: WITHDRAWN ·Phase: PHASE4
-
Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
NCT00344370 ·Status: COMPLETED ·Phase: PHASE3